Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10813885
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
granted -
US 10813366
Bifidobacterium longum NCIMB 41676
granted -
US 10813913
Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)
granted -
US 10815487
Chimeric antigen receptors targeting B-cell maturation antigen
granted -
US 10815305
Methods of treating inflammatory conditions
granted -
US 10815301
Anti-CD30 chimeric antigen receptors
granted -
US 10815225
Antiproliferation compounds and uses thereof
granted -
US 10813894
Methods of inhibiting pain
granted -
US 10813899
Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related compounds, (1s,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
granted -
US 10814010
FOXC2 inhibitor and methods of use thereof
granted -
US 10813909
Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancer
granted -
US 10813918
Use of Gaboxadol in the treatment of diabetes and related conditions
granted -
US 10813917
Treatment methods utilizing stem cell mobilizers and immunosuppressive agents
granted -
US 10813929
Treating cancer with ATR inhibitors
granted -
US 10813934
Sirtuin modulators as inhibitors of cytomegalovirus
granted -
US 10813952
NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
granted -
US 10813993
Display platform from bacterial spore coat proteins
granted -
US 10814006
Fluorescent prodrugs
granted -
US 10814007
Angiotensinogen (AGT) iRNA compositions and methods of use thereof
granted -
US 10813961
Powder formulation having a function of enhancing immunity and method for preparing the same
granted -
US 10814043
Cross-linked fatty acid-based biomaterials
granted -
US 10815229
Benzenesulfonamide compounds and their use as therapeutic agents
granted -
US 10815231
[1,2,4] triazolo [1,5-a] pyridine derivative and crystalline form thereof
granted -
US 10815206
RIP1 inhibitory compounds and methods for making and using the same
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.